Revenue
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | $81,000 | $77,000 | $306,000 | $268,000 | $82,000 | $25,000 |
| Research & development | $13.2M | $14.7M | $15.2M | $14.2M | $11.0M | $7.8M |
| Operating expenses | $36.6M | $36.7M | $40.1M | $45.9M | $35.5M | $18.0M |
| Operating income | −$36.5M | −$36.6M | −$39.8M | −$45.7M | −$35.4M | −$18.0M |
| EBITDAderived | −$35.6M | −$35.8M | −$38.9M | −$44.9M | −$34.7M | −$17.1M |
| Net income | −$31.9M | −$32.9M | −$36.2M | −$44.2M | −$35.0M | −$19.8M |
| Basic EPSper diluted share | -$0.67 | -$0.99 | -$1.16 | -$1.43 | -$2.33 | -$12.76 |
| Diluted EPSper diluted share | -$0.67 | -$0.99 | -$1.16 | -$1.43 | -$2.33 | -$12.76 |
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 11, 2026Form 4 | Inglis Tiffany Eul DavisChief Medical Officer | SellClass A Common Stock | 362 | $2.01 | $727.62 | 92.1K |
| Jun 11, 2026Form 4 | Anderson Dyaarl Lee Jr.Chief Commercial Officer | SellClass A Common Stock | 4.7K | $2.01 | $9.5K | 78.0K |
| Jun 11, 2026Form 4 | Aerts AustinChief Financial Officer | SellClass A Common Stock | 2.0K | $2.01 | $4.1K | 301.2K |
| Jun 11, 2026Form 4 | Lindgardt ZhenyaChief Executive Officer | SellClass A Common Stock | 7.0K | $2.01 | $14.0K | 865.0K |
| Jun 11, 2026Form 4 | Jackson BenjaminGeneral Counsel | SellClass A Common Stock | 2.2K | $2.01 | $4.4K | 161.8K |